相关实验视频

Updated: Jul 18, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

对肝细胞癌的免疫疗法的现实世界使用

Amir Sara¹, Samantha M Ruff², Anne M Noonan¹

¹Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Pragmatic and observational research

|August 28, 2023

概括

肝细胞癌 (HCC) 治疗正在通过免疫疗法发展. 现实世界的数据和正在进行的试验正在探索将免疫检查点抑制剂 (ICI) 与晚期肝癌的其他疗法结合起来.

科学领域:

肝病学肝病学是一种肝病学.
医学瘤学医学瘤学
免疫学免疫学免疫学

背景情况:

肝细胞癌 (HCC) 是全球癌症死亡的主要原因,通常是由病毒性肝炎,酒精和代谢综合征的慢性炎症引起的.
在HCC中的瘤微环境通过招募调节细胞和调高免疫检查点来促进免疫抑制.
调节免疫系统为HCC提供了一个有前途的治疗策略.

研究的目的:

审查免疫检查点抑制剂 (ICI) 在管理HCC当前的现实应用.
突出正在进行的临床试验,研究新型ICI组合用于HCC治疗.
评估免疫治疗对HCC管理和未来治疗模式的影响.

主要方法:

对临床试验数据的审查 (Checkmate 040,Keynote 224,IMbrave 150,HIMALAYA) 关于HCC的免疫治疗疗效.
对实践研究的分析,评估ICI在不同HCC患者群体中的使用情况.
确定和总结正在进行的临床试验,探讨ICI与地方区域治疗的结合.

主要成果:

尼沃卢马布和潘布罗利祖马布等免疫疗法药物在HCC中显示出持久的反应,导致它们被批准作为二线治疗.
组合疗法 (阿特佐利祖马布/贝瓦齐祖马布,特梅利祖马布/杜尔瓦卢马布) 现在是FDA批准的先进HCC的第一线选择.
在更广泛的患者群体中验证临床试验结果时,现实世界的数据至关重要.

结论:

免疫疗法已经显著推进了HCC治疗,提供了新的治疗选择.
结合策略,包括免疫疗法与局部区域疗法,正在研究协同效应.
未来的研究和现实世界的证据将继续塑造先进的HCC推的第一线治疗方法.

关键词:

肝细胞癌是肝细胞癌.免疫疗法免疫疗法免疫治疗的生物标志物肝脏的微环境是一个微环境.现实世界的数据数据.

更多相关视频

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...